Lipid-lowering therapies: Risks in women and evidence-based options

Tina Shah; Salim S. Virani

doi:10.14503/THIJ-18-6691

Lipid-lowering therapies: Risks in women and evidence-based options

Tina Shah
, Salim S. Virani

Research output: Contribution to journal › Comment/debate

1 Citation (Scopus)

Original language	English (US)
Pages (from-to)	238-239
Number of pages	2
Journal	Texas Heart Institute Journal
Volume	45
Issue number	4
DOIs	https://doi.org/10.14503/THIJ-18-6691
Publication status	Published - Aug 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Anticholesteremic agents/therapeutic use
Cardiovascular diseases/ drug therapy/prevention & control
Cholesterol, LDL/blood
Diabetes mellitus, type 2/chemically induced
Drug therapy, combination
Female
Hydroxymethylglutaryl-CoA reductase inhibitors/ therapeutic use
Randomized controlled trials as topic
Sex factors
Treatment outcome

Access to Document

10.14503/THIJ-18-6691

Cite this

@article{681e448d771046e88c44924879de968a,

title = "Lipid-lowering therapies: Risks in women and evidence-based options",

keywords = "Anticholesteremic agents/therapeutic use, Cardiovascular diseases/ drug therapy/prevention \& control, Cholesterol, LDL/blood, Diabetes mellitus, type 2/chemically induced, Drug therapy, combination, Female, Hydroxymethylglutaryl-CoA reductase inhibitors/ therapeutic use, Randomized controlled trials as topic, Sex factors, Treatment outcome",

author = "Tina Shah and Virani, \{Salim S.\}",

year = "2018",

month = aug,

doi = "10.14503/THIJ-18-6691",

language = "English (US)",

volume = "45",

pages = "238--239",

journal = "Texas Heart Institute Journal",

issn = "0730-2347",

publisher = "Texas Heart Institute",

number = "4",

}

TY - JOUR

T1 - Lipid-lowering therapies

T2 - Risks in women and evidence-based options

AU - Shah, Tina

AU - Virani, Salim S.

PY - 2018/8

Y1 - 2018/8

KW - Anticholesteremic agents/therapeutic use

KW - Cardiovascular diseases/ drug therapy/prevention & control

KW - Cholesterol, LDL/blood

KW - Diabetes mellitus, type 2/chemically induced

KW - Drug therapy, combination

KW - Female

KW - Hydroxymethylglutaryl-CoA reductase inhibitors/ therapeutic use

KW - Randomized controlled trials as topic

KW - Sex factors

KW - Treatment outcome

UR - https://www.scopus.com/pages/publications/85055114059

U2 - 10.14503/THIJ-18-6691

DO - 10.14503/THIJ-18-6691

M3 - Comment/debate

C2 - 30374235

AN - SCOPUS:85055114059

SN - 0730-2347

VL - 45

SP - 238

EP - 239

JO - Texas Heart Institute Journal

JF - Texas Heart Institute Journal

IS - 4

ER -

Lipid-lowering therapies: Risks in women and evidence-based options

UN SDGs

Keywords

Access to Document

Other files and links

Cite this